The Financial Times reports today that BD (NYSE: BDX) began discussions with competitors for the sale of its Life Sciences ...

To enable knowledge sharing for laboratory personnel on technological advancement and best practices made towards assessment ...

BD Life Sciences-Biosciences held a two-day workshop at Christian Medical College, Vellore, focusing on advanced technologies ...

Medical devices maker will discuss options for $21bn division with Thermo Fisher, Danaher and other smaller rivals ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today was named to Fortune's 2025 list of America's Most Innovative Companies, ranking in the top 25% of ...

Buy rating initiated! Discover why this medtech leader with strong growth prospects & dividends is worth your attention.

In a clip premiering exclusively with PEOPLE from the Monday, March 31 episode of The Voice, BD.ii and Kolby Cordell put on ...

River Road Asset Management, an investment management company released its “River Road Large Cap Value Select Fund” Q4 2024 ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment ...

BD's recall of Alaris infusion pumps following software issues has been classified as the most severe recall by the FDA. A suspension of sales may hurt the top line going forward.

Bede, the innovative microfinance solutions app, has once again demonstrated its commitment to customers’ needs by increasing ...

New corporate entities have emerged, spun out of iconic giants like Merck, Johnson & Johnson and BD. As the NJBIZ staff was preparing this issue, one of those spinoffs – Kenvue, late of J&J – cut the ...